Merck KGaA, Darmstadt, Germany, generated very strong organic sales growth in the third quarter of 2018. However, this was impacted by negative exchange rate effects.
Our share price
{{ price }}
{{ delta }}
-
Healthcare
Life Science
Performance Materials
Show All Results
Show All Results
Back
Healthcare
- Healthcare Portfolio
- Allergen Immunotherapy*
- Consumer Health*
- Fertility
- General Medicine
- Neurology & Immunology
Life Science
- Clinical and Diagnostics
- Emerging Biotech
- Environmental Testing
- Food and Beverage
- Government & Academic Research
- Industrial
- Pharma and Biopharma Manufacturing
- Pharmaceutical Research
- Pharma Quality Control
Performance Materials
Back
